- Home
- IPHA vs ESCA Comparison
IPHA vs ESCA Comparison
Compare IPHA & ESCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | ESCA |
|---|---|---|
| Founded | 1999 | 1922 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 180.1M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | ESCA |
|---|---|---|
| Price | $1.71 | $12.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 26.6K | ★ 27.5K |
| Earning Date | 09-17-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 4.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | $14,839,695.00 | ★ $241,540,000.00 |
| Revenue This Year | $22.29 | N/A |
| Revenue Next Year | $43.90 | $3.00 |
| P/E Ratio | ★ N/A | $14.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $11.41 |
| 52 Week High | $2.63 | $16.99 |
Technical Indicators
Market Signals| Indicator | IPHA | ESCA |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 58.19 |
| Support Level | $1.64 | $12.67 |
| Resistance Level | $1.81 | $13.14 |
| Average True Range (ATR) | 0.08 | 0.32 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 18.75 | 77.66 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.